Autoantibody Against Gm-Csf Presented By Mhc Class Ii In Autoimmune Pulmonary Alveolar ProteINOSis

被引：0
|
作者：
Hamano, Y. [1 ]
Kida, H. [1 ]
Hirose, M. [2 ]
Matsumuro, A. [2 ]
Suenaga, T. [3 ]
Sarashina, H. [1 ]
Hamasaki, T. [4 ]
Inoue, Y. [2 ]
Arase, H. [3 ]
Kumanogoh, A. [1 ]
机构：
[1] Osaka Univ, Suita, Osaka, Japan
[2] Natl Hosp Org, Kinki Chuo Chest Med Ctr, Sakai, Osaka, Japan
[3] World Premier Int Res Ctr WPI, Immunol Frontier Res Ctr, Suita, Osaka, Japan
[4] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3147
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Plasmapheresis, GM-CSF, and alveolar proteinosis
    Kavuru, MS
    Bonfield, TL
    Thomassen, MJ
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (07) : 1036 - 1036
  • [42] Aerosolized GM-CSF Therapy of Pulmonary Alveolar Proteinosis (PAP).
    Tazawa, R.
    Inoue, Y.
    Takada, T.
    Arai, T.
    Nasuhara, Y.
    Hizawa, N.
    Kasahara, Y.
    Tatsumi, K.
    Hojo, M.
    Yokoba, M.
    Tanaka, N.
    Yamaguchi, E.
    Eda, R.
    Tsuchihashi, Y.
    Oishi, K.
    Terada, M.
    Kaneko, C.
    Nukiwa, T.
    Krischer, J. P.
    Trapnell, B. C.
    Nakata, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [43] Pulmonary alveolar proteinosis: a complete response to GM-CSF therapy
    Barraclough, RM
    Gillies, AJ
    THORAX, 2001, 56 (08) : 664 - 665
  • [44] Neutralization and clearance of GM-CSF by autoantibodies in pulmonary alveolar proteinosis
    Piccoli, Luca
    Campo, Ilaria
    Fregni, Chiara Silacci
    Rodriguez, Blanca Maria Fernandez
    Minola, Andrea
    Sallusto, Federica
    Luisetti, Maurizio
    Corti, Davide
    Lanzavecchia, Antonio
    NATURE COMMUNICATIONS, 2015, 6
  • [45] Human GM-CSF Autoantibodies and Reproduction of Pulmonary Alveolar Proteinosis
    Sakagami, Takuro
    Uchida, Kanji
    Suzuki, Takuji
    Carey, Brenna C.
    Wood, Robert E.
    Wert, Susan E.
    Whitsett, Jeffrey A.
    Trapnell, Bruce C.
    Luisetti, Maurizio
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (27): : 2679 - 2681
  • [46] Neutralization and clearance of GM-CSF by autoantibodies in pulmonary alveolar proteinosis
    Luca Piccoli
    Ilaria Campo
    Chiara Silacci Fregni
    Blanca Maria Fernandez Rodriguez
    Andrea Minola
    Federica Sallusto
    Maurizio Luisetti
    Davide Corti
    Antonio Lanzavecchia
    Nature Communications, 6
  • [47] GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis
    Uchida, Kanji
    Beck, David C.
    Yamamoto, Takashi
    Berclaz, Pierre-Yves
    Abe, Shuichi
    Staudt, Margaret K.
    Carey, Brenna C.
    Filippi, Marie-Dominique
    Wert, Susan E.
    Denson, Lee A.
    Puchalski, Jonathan T.
    Hauck, Diane M.
    Trapnell, Bruce C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (06): : 567 - 579
  • [48] Pulmonary hypertension during high-dose GM-CSF therapy of autoimmune pulmonary alveolar proteinosis
    Ataya, Ali
    Mitchel, Stephen
    Carey, Brenna
    Sippel, Jeffrey
    Mccarthy, Cormac
    Trapnell, Bruce C.
    PULMONARY CIRCULATION, 2024, 14 (04)
  • [49] Current management strategies and the potential of inhaled GM-CSF for the treatment of autoimmune pulmonary alveolar proteinosis
    Piloni, Davide
    Campo, Ilaria
    EXPERT OPINION ON ORPHAN DRUGS, 2019, 7 (03): : 117 - 123
  • [50] Clinical significance of serum anti-GM-CSF autoantibody levels in autoimmune pulmonary alveolar proteinosis
    Nishimura, Masaki
    Yamaguchi, Etsuro
    Takahashi, Ayumu
    Asai, Nobuhiro
    Katsuda, Eisuke
    Ohta, Toyohiro
    Ohtsuka, Yoshinori
    Kosaka, Kenshi
    Matsubara, Ayako
    Tanaka, Hiroyuki
    Yokoe, Norihito
    Kubo, Akihito
    Konno, Satoshi
    Baba, Kenji
    BIOMARKERS IN MEDICINE, 2018, 12 (02) : 151 - 159
12345